Occlutech, the second-largest player in Europe's minimally invasive cardiac implants segment, posted a revenue of 49.4 million for 2025. It derives about 85% of its revenue from Europe and the U.S.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/uYP9FmB
0 Comments